Alterations in pathogen-specific cellular and humoral immunity associated with acute peripheral facial palsy of infectious origin
Authors:
- Mathias FousseMFMathias Fousse
- Gentiana WenzelGWGentiana Wenzel
- Marina Flotats-BastardasMFMarina Flotats-Bastardas
- Klaus FaßbenderKFKlaus Faßbender
- Ulrich DillmannUDUlrich Dillmann
- Bernhard SchickBSBernhard Schick
- Michael ZemlinMZMichael Zemlin
- Barbara C. GärtnerBGBarbara C. Gärtner
- David SchubDSDavid Schub
- Tina SchmidtTSTina Schmidt
Preprint
Abstract
Background and Objectives Peripheral facial palsy (PFP) is a common neurologic symptom which can be triggered by pathogens or autoimmunity as well as trauma, tumors, cholesteatoma and further local conditions disturbing the peripheral section of the nerve. In general, its cause is often difficult to identify, remaining unknown in over two thirds of cases. As we have previously shown that the quantity and quality of pathogen-specific T cells change during active infections, we hypothesized that such changes also may help to identify the causative pathogen in PFPs of unknown origin. Methods Pathogen-specific T cells were quantified in blood samples of 55 patients with PFP and 23 healthy controls after stimulation with antigens from varicella-zoster virus (VZV), herpes-simplex viruses (HSV) or borrelia. T cells were further characterized by expression of the inhibitory surface molecule CTLA-4, and markers for differentiation (CD27) and proliferation (Ki67). Pathogen-specific antibody responses were analyzed using ELISA. Results were compared with conventional diagnostics. Results Patients with PFP were more often HSV-seropositive than controls (p=0.0003), whereas VZV-and borrelia-specific antibodies did not differ between groups. Although the quantity and general phenotypical characteristics of antigen-specific T cells did not differ either, expression of CTLA-4 and Ki67 was highly increased in VZV-specific T cells of 9 PFP patients, of which 5 showed typical signs of cutaneous zoster. In the remaining 4 patients, a causal relationship with VZV was possible but remained unclear by clinical standard diagnostics. A similar CTLA-4- and Ki67-expression profile was also found in a patient with acute neuroborreliosis. Discussion In conclusion, the high prevalence of HSV-seropositivity among PFP-patients may indicate an underestimation of HSV-involvement in PFP, even though HSV-specific T-cell characteristics seem insufficient to identify HSV as a causative agent. In contrast, striking alterations in VZV- and borrelia-specific T-cell phenotype and function may allow identification of VZV- and borrelia-triggered PFPs thus bearing the potential to improve specificity of the clinical diagnosis.Keywords
All Related Versions
- Published version: Journal of Neuroinflammation, 20 (1), 1.
This publication has 33 references indexed in Scilit:
- Bell's palsy and autoimmunityAutoimmunity Reviews, 2012
- Electrical and Transcranial Magnetic Stimulation of the Facial Nerve: Diagnostic Relevance in Acute Isolated Facial Nerve PalsyEuropean Neurology, 2012
- Neuroanatomical correlation of the House-Brackmann grading system in the microsurgical treatment of vestibular schwannomaNeurosurgical Focus, 2012
- The benefits of steroids versus steroids plus antivirals for treatment of Bell's palsy: a meta-analysisBMJ, 2009
- PD-1 Expression and IL-2 Loss of Cytomegalovirus- Specific T Cells Correlates with Viremia and Reversible Functional AnergyAmerican Journal of Transplantation, 2008
- Management of peripheral facial nerve palsyEuropean Archives of Oto-Rhino-Laryngology, 2008
- Diagnostic relevance of transcranial magnetic and electric stimulation of the facial nerve in the management of facial palsyClinical Neurophysiology, 2005
- Bell's PalsyNew England Journal of Medicine, 2004
- Sustained High Frequencies of Specific CD4 T Cells Restricted to a Single Persistent VirusJournal of Virology, 2002
- High Prevalence of Varicella-Zoster Virus Reactivation in Herpes Simplex Virus-Seronegative Patients with Acute Peripheral Facial PalsyClinical Infectious Diseases, 2000